Oman: Tender floated for commercial hub in EZAD Square
The Authority invited experienced Omani-Saudi consortiums to submit bids via the electronic tendering platform 'Esnad.' The deadline for purchasing tender documents is set for June 26, with a site visit scheduled for June 30. The final date for submitting bids is August 11, 2025.
The tender includes the construction of the main square of the Al Dhahirah Integrated Economic Zone, a business centre, an administrative building, a commercial centre, as well as a hotel and a health centre.
The scope of work includes the execution of civil works, electrical and mechanical systems, and steel structures for the buildings. It also covers external works such as the construction of internal roads, sewage networks, water and irrigation systems, and landscaping.
The total land area allocated for the complex is approximately 50,000 square metres, with the first phase covering a built-up area of around 17,000 square metres and the potential to expand to 38,000 square metres.
Eng. Ibrahim Yousuf Al Zadjali, EZAD Project Manager, affirmed that smart city principles have been considered in the design of the facilities. The buildings have also been designed in line with the requirements for obtaining LEED (Leadership in Energy and Environmental Design) green building certification, which will be implemented by the consortium awarded the tender.
Al Dhahirah Integrated Economic Zone is located 20 kilometres from the Empty Quarter border crossing between the Sultanate of Oman and the Kingdom of Saudi Arabia, with a total area of 388 square kilometres.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Khaleej Times
21 minutes ago
- Khaleej Times
Borouge announces $193 million Q2 2025 net profit
Borouge Plc, a leading petrochemicals company providing innovative and differentiated polyolefins solutions, on Thursday announced a net profit of $193 million for the second quarter of 2025, exceeding market expectations. The results reflect execution of the planned Borouge 3 turnaround, with the company maintaining strong margins and healthy cash generation on the back of effective cost management and sustained premia across its high-value product mix. The Borouge 3 turnaround was successfully executed during the quarter, within budget and delivered eight days ahead of schedule. As the largest and most complex turnaround to date, the company optimised downtime by 15 per cent, reflecting the efficiency of company's planning and execution teams. These planned, regular six-year maintenance turnarounds are essential to servicing Borouge's world-class assets and maintaining high utilisation rates and production volumes. Adjusted Ebitda for the second quarter was $440 million, reflecting performance above expectations during the planned Borouge 3 turnaround. Borouge maintained a healthy Ebitda margin of 34 per cent, supported by product mix optimisation throughout a scheduled major maintenance event. The company has proposed an increased minimum interim dividend of 8.1 fils per share for the first half of 2025, subject to shareholder approval at the upcoming General Assembly in August. This interim payout reflects the first instalment of the previously announced intention to increase the full-year 2025 dividend to 16.2 fils per share, marking an uplift from 15.88 fils in 2024, representing an estimated dividend yield of 6.1 per cent at the current share price, one of the highest on the Abu Dhabi Securities Exchange (ADX). This reinforces the company's increased dividend framework. Since its listing in 2022, Borouge has paid a total of $3.58 billion in dividends to shareholders. Upon completion of the proposed Borouge Group International transaction, the newly formed entity intends to maintain an annual minimum dividend of 16.2 fils per share up to at least 2030. This represents a cumulative shareholder return of approximately 37 per cent1 with a strong upside potential and a 90 per cent dividend payout ratio of net profit. Hazeem Sultan Al Suwaidi, chief executive officer of Borouge, commented: 'Borouge's results are underpinned by healthy cash flows, disciplined execution and strong pricing premia, following the successful completion of the planned Borouge 3 turnaround, our largest to date. Reflecting our commitment to delivering shareholder value, we reaffirm our intention to increase Borouge's dividend to 16.2 fils per share for 2025 and our proposed H1 2025 dividend of 8.1 fils per share to be paid in September. The increased dividend is also expected to serve as the intended minimum share payout to at least 2030 under Borouge Group International.' Strong pricing premia above product benchmark prices for polyethylene (PE) and polypropylene (PP) remained a key highlight of the quarter, with $249 per tonne achieved for PE and $141 per tonne for PP, both exceeding management's through-the-cycle guidance. Supported by Borouge's ability to reallocate volumes to maximise netbacks, its differentiated portfolio and disciplined execution, the company sustained premium positioning despite softer market conditions. Resilient Q2 performance anchored by operational excellence Borouge reported revenue of $1.31 billion in Q2 2025, compared to $1.5 billion in Q2 2024, taking into account the planned Borouge 3 maintenance, reflecting a quarter that balanced disciplined asset management with the company's ongoing commitment to delivering value for shareholders. Sales volumes totalled 1.1 million tonnes, broadly stable quarter-on-quarter, supported by approximately 140 kilotonnes of inventory sales. High-value products continued to account for 41 per cent of total volumes, with strong momentum in infrastructure and advanced packaging applications. Average selling prices declined 1 per cent quarter-on-quarter and 3 per cent year-on-year, in line with broader market conditions. While PE prices held steady, PP saw a modest decline. Global benchmarks for PE and PP declined slightly over the same period. Despite this environment, Borouge sustained pricing discipline and continued to optimise its regional sales mix, with an increasing share allocated to Middle East and Borealis-linked markets offering higher netbacks. Adjusted Ebitda for the quarter was $440 million, compared to $613 million in Q2 2024, with an Ebitda margin of 34 per cent. The lower margin reflects lower average selling prices, taking into account reduced production levels during the planned turnaround period. Borouge's ability to maintain a high margin despite lower production demonstrates its cost efficiency, operational control and commercial agility. Capital expenditure in Q2 amounted to $130 million. Borouge closed the quarter with a net debt-to-Ebitda ratio of 1.0x, maintaining a strong balance sheet and significant financial flexibility. For the first half of the year, revenue stood at $2.72 billion compared to $2.81 billion in H1 2024. Adjusted Ebitda reached $1.0 billion versus $1.18 billion in the prior-year period, with margins supported by strong pricing premia, cost discipline and inventory sales. Sales volumes totalled 2.39 million tonnes, down just 2 per cent year-on-year, reflecting Borouge's operational resilience and agility. Borouge continues to execute a share buyback approved at its AGM in April, reflecting the company's strong confidence in its future prospects. It has purchased 125 million shares at the end of the second quarter with transactions reported as per ADX regulatory requirements. Outlook Borouge continues to focus on differentiated products in its core regions, supporting strong price premia and strong performance expected through the second half of the year. The company remains agile in allocating volumes to the best netback markets within its core regions. With the planned turnaround now successfully concluded, it is well positioned to optimise production capacity and to take advantage of improved market dynamics as they emerge.
Khaleej Times
21 minutes ago
- Khaleej Times
PureHealth reports Dh13.6 billion in revenue and Dh1.03 billion in net profit for H1
PureHealth Holding, the largest healthcare group in the Middle East, on Thursday announced a 9 per cent year-on-year revenue increase to Dh13.6 billion in H1 2025, driven by broad-based growth across both its healthcare and insurance verticals. Ebitda rose 8 per cent year-on-year to Dh2.3 billion in H1-2025, while net profit reached Dh1.03 billion, up 2 per cent year-on-year. As part of its continued evolution and transformation of acquired assets, PureHealth is streamlining its operating model built around two core verticals: Care and Cover. This structure brings together all Group businesses under each vertical, with 'Care' encompassing Hospitals, Procurement, Diagnostics, and Technology, while 'Cover' includes the Group's Insurance operations. Kamal Al Maazmi, Chairman of PureHealth, said: 'PureHealth's strong performance in the first half of 2025 reflects the profound ambition driving our transformation, building a global, future-ready healthcare ecosystem that is both technologically advanced and deeply human. By aligning innovation with national priorities and international partnerships, we are not only expanding access to care, but we are also reshaping how health is delivered, experienced, and sustained.' Shaista Asif, Group Chief Executive Officer at PureHealth, commented, 'We delivered solid growth in the first half of 2025 across both our Care and Cover verticals. Our entry into the Property & Casualty segment through Daman strengthens our ability to offer comprehensive, multi-line coverage. We continue to enhance our services through AI-powered solutions that make healthcare more intelligent and efficient. As we expand globally, our focus remains on synergies, transformation of the assets, and delivering better health outcomes within communities we operate.' The Care vertical was the largest contributor to revenue during the period, accounting for 72 per cent of the group's top-line at dh9.8 Billion in revenue, up 7 per cent year-on-year in h1 2025. This growth witnessed across several segments, including hospitals, diagnostics, and technology. Performance in UAE and UK was driven by a 13 per cent increase in outpatient volumes to 4.4 million visits, and a 7 per cent rise in inpatient volumes to 108,000 visits across the Hospitals vertical. In the UAE, this growth was supported by expanded service offerings, increased specialist capacity, and growing demand across SEHA and SSMC networks. In the UK, Circle Health saw increased patient volumes and further strengthened its position through the successful bolt on acquisition of Fairfield Independent Hospital in the Merseyside. The acquisition will expand inpatient capacity and available medical staff, which will ultimately support Circle Health's continued growth in high-demand regions. While Procurement revenue decreased 5 per cent year-on-year to Dh2.6 billion in H1 2025, Rafed has continued expansion of its supplier network. Its recent appointed role as the exclusive distributor for the Abu Dhabi government's Unified Purchasing Programme, has since strengthened its position as a central enabler within the Group's healthcare delivery model. PureLab recorded a 19 per cent year-on-year increase in total testing volume, reaching 16.9 million tests. This strong performance was largely fuelled by enhanced contributions from SEHA and the successful integration of the SSMC laboratory into the PureLab network. The Technology Services reported exceptional growth, with revenue increasing 170 per cent year-on-year to Dh367 million in H1-2025. This was driven by the continued expansion of PureCS, which deployed digital infrastructure and clinical technology solutions across the Group's entities. The Pura app surpassed 620,000 users during the period, while the Group's broader technology backbone is enabling predictive analytics, digital patient engagement, and AI-enhanced care delivery. The Cover vertical revenue increased 14 per cent year-on-year to Dh3.8 billion, supported by an 8 per cent rise in Gross Written Premiums (GWP) to Dh4.9 billion in H1-2025. Growth was further fuelled by new business, driven by expansion into underpenetrated segments and geographies. Membership increased 6 per cent year-on-year, reflecting the Group's compelling value proposition and strong customer retention. PureHealth's balance sheet remains strong, with a Net Debt to Ebitda ratio of 1.4x, providing the Group with ample flexibility to pursue future M&A opportunities and invest in strategic organic growth initiatives across its global healthcare platform. PureHealth repaid Dh1.85 billion in bank debt ahead of its 2027 maturity and currently has no bank debt.
Khaleej Times
21 minutes ago
- Khaleej Times
Response Plus Holding reports Dh248 million revenue in H1
Response Plus Holding PJSC, the largest pre-hospital care and emergency medical services provider in the UAE and KSA, has achieved revenue of Dh248.06 million in the first six months of 2025, a growth of 18% compared to Dh209.88 million recorded in the same period last year. Announcing the company's interim financial results for the first half of 2025, RPM registered net profit of Dh20.32 million, while total assets touched Dh404.32 million, up from Dh387.44 million as of December 31, 2024, reflecting continued balance sheet strength and sustained investment momentum. The Earnings Per Share (EPS) for the period was Dh0.10. As part of its commitment to deliver shareholder value, the Board of Directors has approved an interim cash dividend distribution of Dh18 million to the shareholders. Dr Rohil Raghavan, Chief Executive Officer of Response Plus Holding, said: 'The first half of 2025 reflects our strategic agility and continued investment in excellence. From expanding into new geographies to launching the first-of-its-kind services in the region, we are driving impactful growth while prioritizing operational efficiencies. With a strong foundation and forward-looking initiatives, we are well-positioned to deliver greater value to our clients, partners, and shareholders.' RPM delivered strategic milestones during the first half of 2025, reinforcing its leadership in regional and global emergency medical care. The company expanded its aviation emergency operations to The Bahamas, demonstrating its capabilities to scale internationally while enhancing its disaster and air evacuation readiness. During the Hajj season, the company deployed 350 medical professionals and 125 ambulances in 18 clinics across nine stations of Saudi Arabia Railways to support millions of pilgrims visiting the Holy sites. RPM also signed a MoU with Falcon Aviation to operate the UAE's first air ambulance service, a landmark step in enhancing the country's emergency response infrastructure. RPM currently operates over 420 medical sites through key subsidiaries including Prometheus Medical, Occumed Clinic, Health Tech Training Centre, and Medical Manpower Supply. With operations spanning the UAE, KSA, Oman, India, the UK, Switzerland, and Norway, RPM remains firmly committed to redefining the future of pre-hospital emergency medical services.
